Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Unibios HoldingsATH:BIOSK -2.26%61 3-Year ROIIC % is 7.44 as of Dec. 2025, which is 29% below its 10-year median of 10.48. GuruFocus rates ATH:BIOSK with a GF Score™ of 61/100 and a GF Value™ of €1.48 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 2,933 Industrial Products companies, Unibios Holdings ranks better than 57.62% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Unibios Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 7.44%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Unibios Holdings's 3-Year ROIIC % or its related term are showing as below:
ATH:BIOSK's 3-Year ROIIC % is ranked better than 57.62% of 2933
companies
in the Industrial Products industry
Industry Median: 3.4
vs ATH:BIOSK: 7.44
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Unibios Holdings 3-Year ROIIC % Related Terms
Unibios Holdings 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Unibios Holdings's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ATH:BIOSK vs VLTO, ZWS, CECO: 3-Year ROIIC % Comparison
For the Pollution & Treatment Controls subindustry, Unibios Holdings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Unibios Holdings 3-Year ROIIC % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Unibios Holdings's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Unibios Holdings's 3-Year ROIIC % falls into.
Unibios Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 1.099948 (Dec. 2025) - 0.8395101 (Dec. 2022) )
/
( 26.412 (Dec. 2025) - 22.911 (Dec. 2022) )
=
0.2604379
/
3.501
=
7.44%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Unibios Holdings (ATH:BIOSK) has a 3-Year ROIIC % of 7.44 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Unibios Holdings and its competitors. This is 29% below median its historical median of 10.48. According to the industry distribution chart, Unibios Holdings ranks #1243 out of 2933 companies in the Industrial Products industry, placing it in the top 42.4%.
Is Unibios Holdings' 3-Year ROIIC % too high?
Unibios Holdings' current 3-Year ROIIC % of 7.44 is 29% below median its 10-year median of 10.48. The Industrial Products industry median 3-Year ROIIC % is 3.40. Unibios Holdings' value of 7.44 is 118.8% above this industry median. Based on the distribution chart, Unibios Holdings ranks #1243 out of 2933 companies in the Industrial Products industry, which is above the industry midpoint. Overall, Unibios Holdings has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Unibios Holdings' 3-Year ROIIC % compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, Unibios Holdings ranks #1243 out of 2933 companies for 3-Year ROIIC %. This puts Unibios Holdings in the upper half of its industry. The industry median 3-Year ROIIC % is 3.40. Unibios Holdings' value of 7.44 is 118.8% above this benchmark. While the company's 10-year median is 10.48 vs. the industry median of 3.40, Unibios Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for an Industrial Products company?
The median 3-Year ROIIC % among Industrial Products companies is 3.40, based on 2,933 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Unibios Holdings's current 3-Year ROIIC % of 7.44 is 118.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Unibios Holdings and its competitors. For the Industrial Products industry, the median 3-Year ROIIC % is 3.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Unibios Holdings's current 3-Year ROIIC % is 7.44, which is 29% below median its own 10-year median of 10.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unibios Holdings stock overvalued right now?
Based on GuruFocus' analysis, Unibios Holdings (ATH:BIOSK) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.48, compared to a current price of €2.60 — trading 75.7% above its estimated fair value. The current 3-Year ROIIC % is 7.44, which is 29% below median its 10-year median of 10.48 and 118.8% above the Industrial Products industry median of 3.40. Unibios Holdings' overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Unibios Holdings (ATH:BIOSK), the current 3-Year ROIIC % is 7.44 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Unibios Holdings (ATH:BIOSK) Overvalued in 2026?
Based on GuruFocus' analysis, Unibios Holdings stock appears to be overvalued.
The current stock price of €2.60 is trading 75.7% above its estimated GF Value™ of €1.48.
GuruFocus considers Unibios Holdings to be Significantly Overvalued.
Key valuation signals for ATH:BIOSK:
3-Year ROIIC %: 7.44 (29% below median its 10-year median of 10.48)
GF Value™: €1.48 vs. price of €2.60 (75.7% above fair value)
Industry Position: 118.8% above the Industrial Products median (#1243 of 2933)
No single metric tells the full story. See the ATH:BIOSK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Unibios Holdings SA, through its subsidiaries, provides technologies for the responsible use of water and energy. Its activities include the treatment, filtration, water management, heating, and air conditioning, combined with energy saving.
61GF Score
Get the complete analysis for ATH:BIOSK
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ATH:BIOSK has been successfully added to your 
